AZD-8330 Completed Phase 1 Trials for Malignancies Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00454090AZD8330 First Time in Man in Patients With Advanced Malignancies